Biosimilars are not Generics is to be discussed at SMi's Biosimilars and Biobetters conference

May 9, 2011 - PRLog -- SMi is proud to present its 2nd conference on Biosimilars and Biobetters that will bring together leading figures in the growing market. With billions of dollars worth of biologic drugs going off patient in the next decade, this industry in set to expand at an intensive rate, and the importance of being fully informed of how you and our business will be affected is paramount. By the same token, the rewards of playing an important role in the development of biosimilars, or “Follow On Biologics”, are potentially substantial.

                                                                         Testimonials
“Great conference, right size and mix of people” - Senior Manager, Biogen Idec

“Very well organised, excellent time keeping [...] excellent choice of topic covered” - Patent Editor, IMS Health


This year’s key presentations include:

Next generation monoclonal antibody development and clinical challenges with
biosimilar drug development - Frank Scappaticci, Associate Group Medical Director, Genentech

The developing biosimilars regulatory framework in the U.S. - Ross Lobell, Vice President, Regulatory Affairs, Medimmune

Factors to be considered for Biosimilar CMC development - Hans-Martin Mueller, Associate Director, Biotech Development, Merck

GCSF biosimilar case study - Matthew Turner, Global Medical Leader - Zarzio and Binocrit, Sandoz Biopharmaceuticals

Biosimilar sales forecast in seven unregulated markets in 2016: How large is the opportunity?  - Richard Dicicco, Chairman, Harvest Moon Pharmaceuticals

Register by 31st May and receive a £300 discount!

# # #

Biosimilars and Biobetters is just one of the many conferences that are a part of the SMi Group portfolio.
The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi’s highly targeted conferences, workshops and publications. For more information visit www.smi-online.co.uk